Bidirectional Associations Between Seborrheic Dermatitis and Epithelial Barrier Diseases: A Retrospective Cohort Study

脂溢性皮炎与上皮屏障疾病的双向关联:一项回顾性队列研究

阅读:4

Abstract

BACKGROUND: Seborrheic dermatitis (SD) is a common skin disease characterized by epithelial barrier breakdown. The epithelial barrier theory (EBT) implicates epithelial barrier disruption in the development of epithelial barrier diseases (EBDs). We hypothesized that SD is associated with an increased risk of EBDs and investigated the bidirectional association between SD and EBDs. METHODS: Retrospective cohort study of 5,083,689 patients using a large US administrative claims database from January 1, 2016, to June 30, 2022. The mean (standard deviation) follow-up was 3.25 (1.75) years with a total follow-up of over 16 million person-years. The outcomes were a diagnosis of (i) SD after an EBD and (ii) EBD after SD, analyzed using a multivariable Cox proportional hazards model (hazard ratio [95% confidence interval]). RESULTS: The risk of SD was increased after EBD diagnosis for multiple diseases, including atopic dermatitis [2.46 (2.40, 2.53)], alopecia areata [3.47 (3.24, 3.71)], contact dermatitis [1.92 (1.88, 1.96)], psoriasis [2.62 (2.54, 2.69)], rosacea [2.84 (2.78, 2.90)], hidradenitis suppurativa [1.79 (1.63, 1.97)], rhinosinusitis [1.34 (1.32, 1.35)], food allergy [1.47 (1.42, 1.54)], celiac disease [1.55 (1.43, 1.68)], ocular allergy [1.55 (1.49, 1.61)], and dry eye [1.54 (1.52, 1.56)]. The risk of EBD after SD diagnosis followed similar trends, with the largest effect estimates being psoriasis [3.52 (3.42, 3.61)], rosacea [2.85 (2.79, 2.92)], and alopecia areata [2.81 (2.61, 3.03)]. CONCLUSIONS: Our results support the EBT as a shared driver of EBD pathogenesis at not only local (e.g., skin) barriers but also at non-local sites, including the respiratory, gastrointestinal, and ocular epithelial barriers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。